Molecular characterization of a selected cohort of patients affected by pulmonary metastases of malignant melanoma: Hints from BRAF, NRAS and EGFR evaluation

A Ulivieri; G Cardillo; L Manente; G Paone; Ap Mancuso; L Vigna; Enrico Di Stasio; R Gasbarra; S Girlando; A. Leone

doi:10.18632/oncotarget.4503

Molecular characterization of a selected cohort of patients affected by pulmonary metastases of malignant melanoma: Hints from BRAF, NRAS and EGFR evaluation

A Ulivieri
, G Cardillo
, L Manente
, G Paone
, Ap Mancuso
, L Vigna
, Enrico Di Stasio
, R Gasbarra
, S Girlando
, A. Leone^*

^*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivista › Articolo › peer review

5 Citazioni (Scopus)

Abstract

Melanoma is highly curable in early stages but holds devastating consequences in advanced phases with a median survival of 6-10 months. Lungs are a common metastasis target, but despite this, limited data are available on the molecular status of pulmonary lesions.

Lingua originale	Inglese
pagine (da-a)	19868-19879
Numero di pagine	12
Rivista	Oncotarget
Volume	6
Numero di pubblicazione	23
DOI	https://doi.org/10.18632/oncotarget.4503
Stato di pubblicazione	Pubblicato - 2015

All Science Journal Classification (ASJC) codes

Oncologia

Keywords

BRAF
EGFR
NRAS
Pathology
melanoma
pulmonary metastases

Accesso al documento

10.18632/oncotarget.4503

Altri file e collegamenti

Cita questo

Ulivieri, A., Cardillo, G., Manente, L., Paone, G., Mancuso, A., Vigna, L., Di Stasio, E., Gasbarra, R., Girlando, S., & Leone, A. (2015). Molecular characterization of a selected cohort of patients affected by pulmonary metastases of malignant melanoma: Hints from BRAF, NRAS and EGFR evaluation. Oncotarget, 6(23), 19868-19879. https://doi.org/10.18632/oncotarget.4503

@article{527de89900764be6b87849183e7ba3e2,

title = "Molecular characterization of a selected cohort of patients affected by pulmonary metastases of malignant melanoma: Hints from BRAF, NRAS and EGFR evaluation",

abstract = "Melanoma is highly curable in early stages but holds devastating consequences in advanced phases with a median survival of 6-10 months. Lungs are a common metastasis target, but despite this, limited data are available on the molecular status of pulmonary lesions.",

keywords = "BRAF, EGFR, NRAS, Pathology, melanoma, pulmonary metastases, BRAF, EGFR, NRAS, Pathology, melanoma, pulmonary metastases",

author = "A Ulivieri and G Cardillo and L Manente and G Paone and Ap Mancuso and L Vigna and \{Di Stasio\}, Enrico and R Gasbarra and S Girlando and A. Leone",

year = "2015",

doi = "10.18632/oncotarget.4503",

language = "English",

volume = "6",

pages = "19868--19879",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals LLC",

number = "23",

}

Ulivieri, A, Cardillo, G, Manente, L, Paone, G, Mancuso, A, Vigna, L, Di Stasio, E, Gasbarra, R, Girlando, S & Leone, A 2015, 'Molecular characterization of a selected cohort of patients affected by pulmonary metastases of malignant melanoma: Hints from BRAF, NRAS and EGFR evaluation', Oncotarget, vol. 6, n. 23, pagg. 19868-19879. https://doi.org/10.18632/oncotarget.4503

TY - JOUR

T1 - Molecular characterization of a selected cohort of patients affected by pulmonary metastases of malignant melanoma: Hints from BRAF, NRAS and EGFR evaluation

AU - Ulivieri, A

AU - Cardillo, G

AU - Manente, L

AU - Paone, G

AU - Mancuso, Ap

AU - Vigna, L

AU - Di Stasio, Enrico

AU - Gasbarra, R

AU - Girlando, S

AU - Leone, A.

PY - 2015

Y1 - 2015

N2 - Melanoma is highly curable in early stages but holds devastating consequences in advanced phases with a median survival of 6-10 months. Lungs are a common metastasis target, but despite this, limited data are available on the molecular status of pulmonary lesions.

AB - Melanoma is highly curable in early stages but holds devastating consequences in advanced phases with a median survival of 6-10 months. Lungs are a common metastasis target, but despite this, limited data are available on the molecular status of pulmonary lesions.

KW - BRAF

KW - EGFR

KW - NRAS

KW - Pathology

KW - melanoma

KW - pulmonary metastases

KW - BRAF

KW - EGFR

KW - NRAS

KW - Pathology

KW - melanoma

KW - pulmonary metastases

UR - https://publicatt.unicatt.it/handle/10807/72356

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84939230923&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84939230923&origin=inward

U2 - 10.18632/oncotarget.4503

DO - 10.18632/oncotarget.4503

M3 - Article

SN - 1949-2553

VL - 6

SP - 19868

EP - 19879

JO - Oncotarget

JF - Oncotarget

IS - 23

ER -

Molecular characterization of a selected cohort of patients affected by pulmonary metastases of malignant melanoma: Hints from BRAF, NRAS and EGFR evaluation

Abstract

All Science Journal Classification (ASJC) codes

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo